Morgan Stanley’s RAPT Therapeutics RAPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $144K | Sell |
18,014
-28,539
| -61% | -$228K | ﹤0.01% | 5983 |
|
|
2025
Q1 | $454K | Sell |
46,553
-7,926
| -15% | -$77.4K | ﹤0.01% | 5371 |
|
|
2024
Q4 | $689K | Buy |
54,479
+16,074
| +42% | +$203K | ﹤0.01% | 5281 |
|
|
2024
Q3 | $618K | Sell |
38,405
-108,957
| -74% | -$1.75M | ﹤0.01% | 5302 |
|
|
2024
Q2 | $3.6M | Sell |
147,362
-90,805
| -38% | -$2.22M | ﹤0.01% | 4151 |
|
|
2024
Q1 | $17.1M | Sell |
238,167
-23,167
| -9% | -$1.66M | ﹤0.01% | 2864 |
|
|
2023
Q4 | $52M | Buy |
261,334
+166,095
| +174% | +$33M | ﹤0.01% | 2409 |
|
|
2023
Q3 | $12.7M | Sell |
95,239
-16,639
| -15% | -$2.21M | ﹤0.01% | 2902 |
|
|
2023
Q2 | $16.7M | Buy |
111,878
+15,106
| +16% | +$2.26M | ﹤0.01% | 2647 |
|
|
2023
Q1 | $14.2M | Buy |
96,772
+1,999
| +2% | +$293K | ﹤0.01% | 2804 |
|
|
2022
Q4 | $15M | Sell |
94,773
-1,761
| -2% | -$279K | ﹤0.01% | 2634 |
|
|
2022
Q3 | $18.6M | Sell |
96,534
-33,910
| -26% | -$6.53M | ﹤0.01% | 2264 |
|
|
2022
Q2 | $19M | Sell |
130,444
-1,551
| -1% | -$226K | ﹤0.01% | 2345 |
|
|
2022
Q1 | $23.2M | Buy |
131,995
+7,011
| +6% | +$1.23M | ﹤0.01% | 1953 |
|
|
2021
Q4 | $36.7M | Buy |
124,984
+29,516
| +31% | +$8.67M | ﹤0.01% | 1576 |
|
|
2021
Q3 | $23.7M | Buy |
95,468
+52,127
| +120% | +$12.9M | ﹤0.01% | 1911 |
|
|
2021
Q2 | $11M | Buy |
43,341
+35,893
| +482% | +$9.13M | ﹤0.01% | 2862 |
|
|
2021
Q1 | $1.32M | Sell |
7,448
-4,416
| -37% | -$784K | ﹤0.01% | 4553 |
|
|
2020
Q4 | $1.87M | Buy |
11,864
+11,612
| +4,608% | +$1.83M | ﹤0.01% | 4221 |
|
|
2020
Q3 | $65K | Sell |
252
-738
| -75% | -$190K | ﹤0.01% | 5617 |
|
|
2020
Q2 | $229K | Buy |
990
+963
| +3,567% | +$223K | ﹤0.01% | 5015 |
|
|
2020
Q1 | $5K | Sell |
27
-339
| -93% | -$62.8K | ﹤0.01% | 6220 |
|
|
2019
Q4 | $82K | Buy |
+366
| New | +$82K | ﹤0.01% | 5710 |
|